{"count": 8, "results": [{"_id": "11077467", "pmid": 11077467, "title": "Glyburide/metformin (Glucovance) for type 2 diabetes.", "journal": "Med Lett Drugs Ther", "date": "2000-11-13T00:00:00Z", "meta_date_publication": "2000 Nov 13", "meta_volume": "42", "meta_issue": "1092", "meta_pages": "105-6", "score": 50088.69, "text_hl": "@CHEMICAL_Glyburide @CHEMICAL_MESH:D005905 @@@Glyburide@@@/@CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@ (@<m>CHEMICAL_Glucovance</m> @CHEMICAL_MESH:C417231 @@@Glucovance@@@) for @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@type 2 diabetes@@@.", "citations": {"NLM": "Glyburide/metformin (Glucovance) for type 2 diabetes. Med Lett Drugs Ther. 2000 Nov 13;42(1092):105-6. PMID: 11077467", "BibTeX": "@article{11077467, title={Glyburide/metformin (Glucovance) for type 2 diabetes.}, journal={Med Lett Drugs Ther}, volume={42}, number={1092}, pages={105-6}}"}}, {"_id": "12945247", "pmid": 12945247, "title": "[Medication of the month. Glucovance in type 2 diabetes, a fixed combination of metformin-glibenclamide for the treatment of a bipolar metabolic disease].", "journal": "Rev Med Liege", "authors": ["Scheen AJ"], "date": "2003-06-01T00:00:00Z", "meta_date_publication": "2003 Jun", "meta_volume": "58", "meta_issue": "6", "meta_pages": "448-52", "score": 50078.348, "text_hl": "[Medication of the month. @<m>CHEMICAL_Glucovance</m> @CHEMICAL_MESH:C417231 @@@Glucovance@@@ in @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@type 2 diabetes@@@, a fixed combination of @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@-@CHEMICAL_Glyburide @CHEMICAL_MESH:D005905 @@@glibenclamide@@@ for the treatment of a @DISEASE_Metabolic_Diseases @DISEASE_MESH:D008659 @@@bipolar metabolic disease@@@].", "citations": {"NLM": "Scheen AJ. [Medication of the month. Glucovance in type 2 diabetes, a fixed combination of metformin-glibenclamide for the treatment of a bipolar metabolic disease]. Rev Med Liege. 2003 Jun;58(6):448-52. PMID: 12945247", "BibTeX": "@article{12945247, title={[Medication of the month. Glucovance in type 2 diabetes, a fixed combination of metformin-glibenclamide for the treatment of a bipolar metabolic disease].}, author={Scheen AJ}, journal={Rev Med Liege}, volume={58}, number={6}, pages={448-52}}"}}, {"_id": "16846398", "pmid": 16846398, "title": "Beta-cell response to metformin-glibenclamide combination tablets (Glucovance) in patients with type 2 diabetes.", "journal": "Int J Clin Pract", "authors": ["Bruce S", "Park JS", "Fiedorek FT", "Howlett HC"], "date": "2006-07-01T00:00:00Z", "doi": "10.1111/j.1742-1241.2006.00994.x", "meta_date_publication": "2006 Jul", "meta_volume": "60", "meta_issue": "7", "meta_pages": "783-90", "score": 50071.883, "text_hl": "Beta-cell response to @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@-@CHEMICAL_Glyburide @CHEMICAL_MESH:D005905 @@@glibenclamide@@@ combination tablets (@<m>CHEMICAL_Glucovance</m> @CHEMICAL_MESH:C417231 @@@Glucovance@@@) in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@type 2 diabetes@@@.", "citations": {"NLM": "Bruce S, Park JS, Fiedorek FT, Howlett HC. Beta-cell response to metformin-glibenclamide combination tablets (Glucovance) in patients with type 2 diabetes. Int J Clin Pract. 2006 Jul;60(7):783-90. PMID: 16846398", "BibTeX": "@article{16846398, title={Beta-cell response to metformin-glibenclamide combination tablets (Glucovance) in patients with type 2 diabetes.}, author={Bruce S and Park JS and Fiedorek FT and Howlett HC}, journal={Int J Clin Pract}, volume={60}, number={7}, pages={783-90}}"}}, {"_id": "15588116", "pmid": 15588116, "title": "Tolerability profile of metformin/glibenclamide combination tablets (Glucovance): a new treatment for the management of type 2 diabetes mellitus.", "journal": "Drug Saf", "authors": ["Davidson JA", "Scheen AJ", "Howlett HC"], "date": "2004-01-01T00:00:00Z", "doi": "10.2165/00002018-200427150-00004", "meta_date_publication": "2004", "meta_volume": "27", "meta_issue": "15", "meta_pages": "1205-16", "score": 50071.72, "text_hl": "Tolerability profile of @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@/@CHEMICAL_Glyburide @CHEMICAL_MESH:D005905 @@@glibenclamide@@@ combination tablets (@<m>CHEMICAL_Glucovance</m> @CHEMICAL_MESH:C417231 @@@Glucovance@@@): a new treatment for the management of @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@.", "citations": {"NLM": "Davidson JA, Scheen AJ, Howlett HC. Tolerability profile of metformin/glibenclamide combination tablets (Glucovance): a new treatment for the management of type 2 diabetes mellitus. Drug Saf. 2004;27(15):1205-16. PMID: 15588116", "BibTeX": "@article{15588116, title={Tolerability profile of metformin/glibenclamide combination tablets (Glucovance): a new treatment for the management of type 2 diabetes mellitus.}, author={Davidson JA and Scheen AJ and Howlett HC}, journal={Drug Saf}, volume={27}, number={15}, pages={1205-16}}"}}, {"_id": "12147149", "pmid": 12147149, "title": "Improved glycaemic control with metformin-glibenclamide combined tablet therapy (Glucovance) in Type 2 diabetic patients inadequately controlled on metformin.", "journal": "Diabet Med", "authors": ["Marre M", "Howlett H", "Lehert P", "Allavoine T"], "date": "2002-08-01T00:00:00Z", "doi": "10.1046/j.1464-5491.2002.00774.x", "meta_date_publication": "2002 Aug", "meta_volume": "19", "meta_issue": "8", "meta_pages": "673-80", "score": 50063.777, "text_hl": "Improved glycaemic control with @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@-@CHEMICAL_Glyburide @CHEMICAL_MESH:D005905 @@@glibenclamide@@@ combined tablet therapy (@<m>CHEMICAL_Glucovance</m> @CHEMICAL_MESH:C417231 @@@Glucovance@@@) in @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@Type 2 diabetic@@@ @SPECIES_9606 @@@patients@@@ inadequately controlled on @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@.", "citations": {"NLM": "Marre M, Howlett H, Lehert P, Allavoine T. Improved glycaemic control with metformin-glibenclamide combined tablet therapy (Glucovance) in Type 2 diabetic patients inadequately controlled on metformin. Diabet Med. 2002 Aug;19(8):673-80. PMID: 12147149", "BibTeX": "@article{12147149, title={Improved glycaemic control with metformin-glibenclamide combined tablet therapy (Glucovance) in Type 2 diabetic patients inadequately controlled on metformin.}, author={Marre M and Howlett H and Lehert P and Allavoine T}, journal={Diabet Med}, volume={19}, number={8}, pages={673-80}}"}}, {"_id": "12452739", "pmid": 12452739, "title": "Pharmacokinetics and pharmacodynamics of glyburide/metformin tablets (Glucovance) versus equivalent doses of glyburide and metformin in patients with type 2 diabetes.", "journal": "Clin Pharmacokinet", "authors": ["Donahue SR", "Turner KC", "Patel S"], "date": "2002-01-01T00:00:00Z", "doi": "10.2165/00003088-200241150-00004", "meta_date_publication": "2002", "meta_volume": "41", "meta_issue": "15", "meta_pages": "1301-9", "score": 50061.008, "text_hl": "Pharmacokinetics and pharmacodynamics of @CHEMICAL_Glyburide @CHEMICAL_MESH:D005905 @@@glyburide@@@/@CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@ tablets (@<m>CHEMICAL_Glucovance</m> @CHEMICAL_MESH:C417231 @@@Glucovance@@@) versus equivalent doses of @CHEMICAL_Glyburide @CHEMICAL_MESH:D005905 @@@glyburide@@@ and @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@type 2 diabetes@@@.", "citations": {"NLM": "Donahue SR, Turner KC, Patel S. Pharmacokinetics and pharmacodynamics of glyburide/metformin tablets (Glucovance) versus equivalent doses of glyburide and metformin in patients with type 2 diabetes. Clin Pharmacokinet. 2002;41(15):1301-9. PMID: 12452739", "BibTeX": "@article{12452739, title={Pharmacokinetics and pharmacodynamics of glyburide/metformin tablets (Glucovance) versus equivalent doses of glyburide and metformin in patients with type 2 diabetes.}, author={Donahue SR and Turner KC and Patel S}, journal={Clin Pharmacokinet}, volume={41}, number={15}, pages={1301-9}}"}}, {"_id": "15529514", "pmid": 15529514, "title": "Durable efficacy of metformin/glibenclamide combination tablets (Glucovance) during 52 weeks of open-label treatment in type 2 diabetic patients with hyperglycaemia despite previous sulphonylurea monotherapy.", "journal": "Int J Clin Pract", "authors": ["Blonde L", "Joyal S", "Henry D", "Howlett H"], "date": "2004-09-01T00:00:00Z", "doi": "10.1111/j.1742-1241.2004.00316.x", "meta_date_publication": "2004 Sep", "meta_volume": "58", "meta_issue": "9", "meta_pages": "820-6", "score": 50056.152, "text_hl": "Durable efficacy of @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@/@CHEMICAL_Glyburide @CHEMICAL_MESH:D005905 @@@glibenclamide@@@ combination tablets (@<m>CHEMICAL_Glucovance</m> @CHEMICAL_MESH:C417231 @@@Glucovance@@@) during 52 weeks of open-label treatment in @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@type 2 diabetic@@@ @SPECIES_9606 @@@patients@@@ with hyperglycaemia despite previous @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@sulphonylurea@@@ monotherapy.", "citations": {"NLM": "Blonde L, Joyal S, Henry D, Howlett H. Durable efficacy of metformin/glibenclamide combination tablets (Glucovance) during 52 weeks of open-label treatment in type 2 diabetic patients with hyperglycaemia despite previous sulphonylurea monotherapy. Int J Clin Pract. 2004 Sep;58(9):820-6. PMID: 15529514", "BibTeX": "@article{15529514, title={Durable efficacy of metformin/glibenclamide combination tablets (Glucovance) during 52 weeks of open-label treatment in type 2 diabetic patients with hyperglycaemia despite previous sulphonylurea monotherapy.}, author={Blonde L and Joyal S and Henry D and Howlett H}, journal={Int J Clin Pract}, volume={58}, number={9}, pages={820-6}}"}}, {"_id": "12877648", "pmid": 12877648, "title": "Glyburide/metformin tablets: a new therapeutic option for the management of Type 2 diabetes.", "journal": "Expert Opin Pharmacother", "authors": ["Dailey GE"], "date": "2003-08-01T00:00:00Z", "doi": "10.1517/14656566.4.8.1417", "meta_date_publication": "2003 Aug", "meta_volume": "4", "meta_issue": "8", "meta_pages": "1417-30", "score": 50054.027, "text_hl": "A new single-tablet of @CHEMICAL_Glyburide @CHEMICAL_MESH:D005905 @@@glyburide@@@/@CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@ combination therapy (@<m>CHEMICAL_Glucovance</m> @CHEMICAL_MESH:C417231 @@@Glucovance@@@), Bristol-Myers Squibb, Inc.) has recently been developed, which addresses the primary defects of @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@Type 2 diabetes@@@: @DISEASE_Insulinoma @DISEASE_MESH:D007340 @@@beta-cell dysfunction@@@ and @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance@@@. ", "citations": {"NLM": "Dailey GE. Glyburide/metformin tablets: a new therapeutic option for the management of Type 2 diabetes. Expert Opin Pharmacother. 2003 Aug;4(8):1417-30. PMID: 12877648", "BibTeX": "@article{12877648, title={Glyburide/metformin tablets: a new therapeutic option for the management of Type 2 diabetes.}, author={Dailey GE}, journal={Expert Opin Pharmacother}, volume={4}, number={8}, pages={1417-30}}"}}]}